Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

ABBV

8 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in AbbVie Inc.

Yes. JPMorgan Chase holds 47,862,796 shares of ABBV (AbbVie), worth $12.2B, as of its Q2 2026 13F filing. It reduced the position by 8,878,895 shares (-15.7%) from Q1 2026. JPMorgan Chase has held ABBV in every 13F on record since Q3 2024, 8 quarterly filings. ABBV is 0.7% of JPMorgan Chase's reported 13F portfolio.

Current Value

$12.2B

Current Shares

47.9M

Total Value Change

+$1.8B

Total Shares Change

-4.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
47.9M
-15.7%
$12.2B0.7%$248.34
0
2026-Q1
Increased
56.7M
+8.3%
$12.1B0.8%$212.87
49
2025-Q4
Decreased
52.4M
-7.3%
$12B0.8%$221.85
0
2025-Q3
Decreased
56.5M
-1.2%
$13.1B0.8%$223.20
0
2025-Q2
Increased
57.2M
+4.5%
$10.6B0.7%$177.40
47
2025-Q1
Increased
54.8M
+5.8%
$11.5B0.8%$198.41
48
2024-Q4
Decreased
51.8M
-1.1%
$9.2B0.7%$166.71
0
2024-Q3
First report
52.3M
-
$10.3B0.8%$183.80
0

Other major holders of ABBV: Vanguard Group Inc., BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used